Q3 FY2022 · Quarterly report
88 pages
Read TScan Therapeutics, Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
TScan Therapeutics, Inc.
NNASDAQ:TCRX0.21
USD
+0.02
(+11.11%)
